Journal Article

Complementary approaches to understanding the role of proteases and their natural inhibitors in neoplastic development: retrospect and prospect

Harry Rubin

in Carcinogenesis

Volume 24, issue 5, pages 803-816
Published in print May 2003 | ISSN: 0143-3334
Published online May 2003 | e-ISSN: 1460-2180 | DOI:
Complementary approaches to understanding the role of proteases and their natural inhibitors in neoplastic development: retrospect and prospect

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics


Show Summary Details


A great deal of evidence has accumulated in recent years for an important but complex role for proteases in tumor development. However, attempts to treat cancer in humans with anti-proteases have been disappointing, and it has been suggested that more basic groundwork is needed before anti-proteases can be effectively applied. Considerable basic information comes from the recognition that earlier results on transformation of chicken embryo fibroblasts (CEF) by the Bryan strain of Rous sarcoma virus (B-RSV) can be explained in terms of proteases and their inhibitors. In particular, the full but reversible normalization of discrete transformed foci by appropriate concentrations of fetal bovine or of calf serum implies a causal role for multiple proteases in transformation, and the efficacy of treatment with a physiological balance of their natural inhibitors. Addition of certain proteases to contact-inhibited normal cultures was then found to stimulate their proliferation. The toxicity of medium produced by CEF heavily transformed with B-RSV suggests that cachexia and other systemic effects of human cancer may result from vascular dissemination of peptides from pericellular proteolysis within tumors. Comprehensive studies revealed significant increases of plasminogen activator and matrix metalloproteinases (MMPs) after infection of CEF with other strains of RSV, and correlation of the proteases with aspects of transformation. A similar role for proteases is indicated in the transformation of mammalian cells by chemical and physical agents. The information gained from functional experiments on cell transformation in culture is complementary to that obtained from the molecular identification of proteases and their inhibitors in all stages of tumor development. The speed, quantification and easy manipulation of the RSV-CEF transformation assay can be combined with current methods of characterizing proteases and anti-proteases to further enrich our basic knowledge of neoplastic development in cells, and facilitate its application to the treatment of cancer.

Keywords: CS, calf serum; CEF, chicken embryo fibroblasts; ECM, extracellular matrix; FBS, fetal bovine serum; MMPs, matrix metalloproteinases; PA, plasminogen activator; PAHs, polycyclic aromatic hydrocarbons; RSV, Rous sarcoma virus (B-RSV, Bryan high titer strain of RSV; SR-RSV, Schmidt-Ruppin strain of RSV); TIMPs, tissue inhibitors of metalloproteinases; TPA, 12-O-tetradecanoyl phorbol-13-acetate, aka PMA (phorbol myristate acetate).

Journal Article.  14423 words. 

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.